IMPROVED PROGNOSIS OF TYPE-I AND TYPE-II DIABETIC-PATIENTS WITH NEPHROPATHY

被引：0
|
作者：
HASSLACHER, C
BORGHOLTE, G
PANRADL, U
WAHL, P
机构：
来源：
MEDIZINISCHE KLINIK | 1990年 / 85卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：643 / 646
页数：4
相关论文
共 50 条
  • [1] INSULIN KINETICS IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    NAVALESI, R
    BENZI, L
    PILO, A
    MARCHETTI, P
    CECCHETTI, P
    MASONI, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1492 - 1492
  • [2] CAPTOPRIL IN THE TREATMENT OF HYPERTENSION IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    GAMBARO, G
    MORBIATO, F
    CICERELLO, E
    DELTURCO, M
    SARTORI, L
    DANGELO, A
    CREPALDI, G
    JOURNAL OF HYPERTENSION, 1985, 3 : S149 - S151
  • [3] CAPTOPRIL IN THE TREATMENT OF HYPERTENSION IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    DANGELO, A
    SARTORI, L
    GAMBARO, G
    GIANNINI, S
    MALVASI, L
    BENETOLLO, P
    LAVAGNINI, T
    CREPALDI, G
    POSTGRADUATE MEDICAL JOURNAL, 1986, 62 : 69 - 72
  • [4] DIABETIC NEPHROPATHY - ARE THERE DIFFERENCES BETWEEN TYPE-I AND TYPE-II
    RITZ, E
    HASSLACHER, C
    TSCHOPE, W
    MINERAL AND ELECTROLYTE METABOLISM, 1990, 16 (01) : 69 - 72
  • [5] NEPHROPROTECTIVE EFFECTS OF NITRENDIPINE IN HYPERTENSIVE TYPE-I AND TYPE-II DIABETIC-PATIENTS
    BRETZEL, RG
    BOLLEN, CC
    MAESER, E
    FEDERLIN, KF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) : 53 - 64
  • [6] INCREASED FIBRINOLYTIC POTENTIAL INDUCED BY GLICLAZIDE IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    GRAM, J
    JESPERSEN, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 25 - 29
  • [7] EFFECTS OF DIFFERENT ANTIHYPERTENSIVE AGENTS IN NORMOTENSIVE MICROALBUMINURIC TYPE-I AND TYPE-II DIABETIC-PATIENTS
    ALLEN, T
    COOPER, ME
    JERUMS, G
    DELUISE, M
    ALFORD, F
    DOYLE, AE
    HAMMOND, J
    MASHFORD, M
    MCMENAMIN, C
    RAFFAELE, J
    WESTWOOD, B
    KIDNEY INTERNATIONAL, 1994, 45 (04) : 1270 - 1271
  • [8] LIPID PROFILE IN TYPE-I DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY
    KOCH, M
    WEBER, K
    GRABENSEE, B
    KIDNEY INTERNATIONAL, 1995, 47 (03) : 985 - 985
  • [9] SERUM SOMATOMEDIN-C IN TYPE-I DIABETIC-PATIENTS WITH NEPHROPATHY
    VERRILLO, A
    DETERESA, A
    VERRILLO, L
    MARTINO, C
    DICHIARA, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 316 - 316
  • [10] DIABETIC GLOMERULOPATHY IN TYPE-II PATIENTS - IS IT DIFFERENT FROM TYPE-I
    SCHMITZ, A
    GUNDERSEN, HJG
    MOGENSEN, CE
    OSTERBY, R
    ACTA ENDOCRINOLOGICA, 1986, 112 : 13 - 13
12345